CRM vs META: Which Is the Better Buy?

Side-by-side comparison of Salesforce, Inc. and Meta Platforms, Inc. — fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-04-29.
Salesforce, Inc. · Technology
$182.14
+45.0% upside to fair value
Grade B High Quality
VS
Meta Platforms, Inc. · Communication Services
$671.34
+36.4% upside to fair value
Grade B High Quality
QuantHub Verdict
CRM has more upside to fair value (+45.0%). CRM trades at a lower forward P/E (22.8x). These are model outputs — not personalized investment advice. See all research →
Valuation & Fundamentals
Metric CRM META
Current Price $182.14 $671.34
Fair Value Estimate $264.10 $916.00
Upside to Fair Value +45.0% +36.4%
Market Cap $173.0B $1,698.2B
Forward P/E 22.8x 28.0x
EV / EBITDA 14.4x 16.5x
Price / Sales 4.2x 8.4x
Price / FCF 12.0x 36.8x
Revenue Growth YoY +12.1% +23.8%
Gross Margin 77.7% 82.0%
Operating Margin 21.5% 41.4%
Return on Equity 12.4% 30.6%
Dividend Yield 0% 0%
FCF Yield 8.33% 2.72%
Analyst Consensus Buy Strong Buy
Investment Thesis
CRM — Salesforce, Inc.
Salesforce, Inc. is a leading enterprise software company specializing in cloud-based customer relationship management and enterprise applications. The company benefits from a durable competitive moat anchored by pioneering SaaS delivery, a large and growing customer base, and a diversified revenue mix with Service Cloud as the largest segment generating $9.05 billion in FY2025. Salesforce exhibi…
META — Meta Platforms, Inc.
Meta Platforms, Inc. operates a leading global social media and technology platform primarily through its Family of Apps segment, which generates over 98% of its $201 billion 2025 revenue, driven by strong advertising growth. The company maintains a high-quality business with a durable competitive moat supported by network effects, brand strength, and intangible assets, reflected in a 30.6% retur…
Accumulation Zones
Metric CRM META
Zone Low $198.08 $687.00
Zone High $224.49 $778.60
In Buy Zone? Yes Yes
← CRM Research    META Research →    All Research